These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 26590100)

  • 1. Discovery of benzamides as potent human β3 adrenergic receptor agonists.
    Zhu C; Kar NF; Li B; Costa M; Dingley KH; Di Salvo J; Ha SN; Hurley AL; Li X; Miller RR; Salituro GM; Struthers M; Weber AE; Hale JJ; Edmondson SD
    Bioorg Med Chem Lett; 2016 Jan; 26(1):55-9. PubMed ID: 26590100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of piperazine benzamides as human β
    Harper BH; Wang L; Zhu C; Kar NF; Li B; Moyes CR; Goble SD; Costa M; Dingley K; Di Salvo J; Ha SN; Hurley A; Li X; Miller RR; Nagabukuro H; Salituro GM; Smith S; Struthers M; Hale JJ; Edmondson SD; Berger R
    Bioorg Med Chem Lett; 2017 Feb; 27(4):1094-1098. PubMed ID: 28089699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and evaluation of conformationally restricted acetanilides as potent and selective β3 adrenergic receptor agonists for the treatment of overactive bladder.
    Moyes CR; Berger R; Goble SD; Harper B; Shen DM; Wang L; Bansal A; Brown PN; Chen AS; Dingley KH; Di Salvo J; Fitzmaurice A; Gichuru LN; Hurley AL; Jochnowitz N; Miller RR; Mistry S; Nagabukuro H; Salituro GM; Sanfiz A; Stevenson AS; Villa K; Zamlynny B; Struthers M; Weber AE; Edmondson SD
    J Med Chem; 2014 Feb; 57(4):1437-53. PubMed ID: 24437735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterocyclic acetamide and benzamide derivatives as potent and selective beta3-adrenergic receptor agonists with improved rodent pharmacokinetic profiles.
    Goble SD; Wang L; Howell KL; Bansal A; Berger R; Brockunier L; DiSalvo J; Feighner S; Harper B; He J; Hurley A; Hreniuk D; Parmee E; Robbins M; Salituro G; Sanfiz A; Streckfuss E; Watkins E; Weber AE; Struthers M; Edmondson SD
    Bioorg Med Chem Lett; 2010 Mar; 20(6):1895-9. PubMed ID: 20181479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of Novel Indazole Derivatives as Orally Available β
    Wada Y; Nakano S; Morimoto A; Kasahara KI; Hayashi T; Takada Y; Suzuki H; Niwa-Sakai M; Ohashi S; Mori M; Hirokawa T; Shuto S
    J Med Chem; 2017 Apr; 60(8):3252-3265. PubMed ID: 28355078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of Novel Indazole Derivatives as Highly Potent and Selective Human β3-Adrenergic Receptor Agonists with the Possibility of Having No Cardiovascular Side Effects.
    Wada Y; Shirahashi H; Iwanami T; Ogawa M; Nakano S; Morimoto A; Kasahara K; Tanaka E; Takada Y; Ohashi S; Mori M; Shuto S
    J Med Chem; 2015 Aug; 58(15):6048-57. PubMed ID: 26125514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of N-phenyl-(2-aminothiazol-4-yl)acetamides with phenoxypropanolamine moiety as selective β3-adrenergic receptor agonists.
    Maruyama T; Onda K; Suzuki T; Hayakawa M; Takahashi T; Matsui T; Takasu T; Nagase I; Ohta M
    Chem Pharm Bull (Tokyo); 2012; 60(5):647-58. PubMed ID: 22689403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological profile of β3-adrenoceptor agonists in clinical development for the treatment of overactive bladder syndrome.
    Igawa Y; Michel MC
    Naunyn Schmiedebergs Arch Pharmacol; 2013 Mar; 386(3):177-83. PubMed ID: 23263450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymmetric synthesis of cis-2,5-disubstituted pyrrolidine, the core scaffold of β3-AR agonists.
    Xu F; Chung JY; Moore JC; Liu Z; Yoshikawa N; Hoerrner RS; Lee J; Royzen M; Cleator E; Gibson AG; Dunn R; Maloney KM; Alam M; Goodyear A; Lynch J; Yasuda N; Devine PN
    Org Lett; 2013 Mar; 15(6):1342-5. PubMed ID: 23451898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of highly potent and selective biphenylacylsulfonamide-based beta3-adrenergic receptor agonists and evaluation of physical properties as potential overactive bladder therapies: part 5.
    Hattori K; Toda S; Imanishi M; Itou S; Nakajima Y; Washizuka K; Araki T; Hamashima H; Tomishima Y; Sakurai M; Matsui S; Imamura E; Ueshima K; Yamamoto T; Yamamoto N; Ishikawa H; Nakano K; Unami N; Hamada K; Matsumura Y; Takamura F
    J Med Chem; 2009 May; 52(9):3063-72. PubMed ID: 19366244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of a novel pyrrolidine scaffold utilized in the discovery of potent and selective human β3 adrenergic receptor agonists.
    Morriello GJ; Wendt HR; Bansal A; Di Salvo J; Feighner S; He J; Hurley AL; Hreniuk DL; Salituro GM; Reddy MV; Galloway SM; McGettigan KK; Laws G; McKnight C; Doss GA; Tsou NN; Black RM; Morris J; Ball RG; Sanfiz AT; Streckfuss E; Struthers M; Edmondson SD
    Bioorg Med Chem Lett; 2011 Mar; 21(6):1865-70. PubMed ID: 21353541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of highly potent and selective biphenylacylsulfonamide-based beta3-adrenergic receptor agonists and molecular modeling based on the solved X-ray structure of the beta2-adrenergic receptor: part 6.
    Hattori K; Orita M; Toda S; Imanishi M; Itou S; Nakajima Y; Tanabe D; Washizuka K; Araki T; Sakurai M; Matsui S; Imamura E; Ueshima K; Yamamoto T; Yamamoto N; Ishikawa H; Nakano K; Unami N; Hamada K; Matsumura Y; Takamura F
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4679-83. PubMed ID: 19608416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Desirable properties of β3-adrenoceptor agonists: implications for the selection of drug development candidates.
    Michel MC; Cernecka H; Ochodnicky P
    Eur J Pharmacol; 2011 Apr; 657(1-3):1-3. PubMed ID: 21315709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of a novel series of benzoic acid derivatives as potent and selective human beta3 adrenergic receptor agonists with good oral bioavailability. 3. Phenylethanolaminotetraline (PEAT) skeleton containing biphenyl or biphenyl ether moiety.
    Imanishi M; Nakajima Y; Tomishima Y; Hamashima H; Washizuka K; Sakurai M; Matsui S; Imamura E; Ueshima K; Yamamoto T; Yamamoto N; Ishikawa H; Nakano K; Unami N; Hamada K; Matsumura Y; Takamura F; Hattori K
    J Med Chem; 2008 Aug; 51(15):4804-22. PubMed ID: 18651730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The odd sibling: features of β3-adrenoceptor pharmacology.
    Cernecka H; Sand C; Michel MC
    Mol Pharmacol; 2014 Nov; 86(5):479-84. PubMed ID: 24890609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of novel acetanilide derivatives as potent and selective beta3-adrenergic receptor agonists.
    Maruyama T; Onda K; Hayakawa M; Matsui T; Takasu T; Ohta M
    Eur J Med Chem; 2009 Jun; 44(6):2533-43. PubMed ID: 19232786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta2- and beta3-adrenoceptors activate glucose uptake in chick astrocytes by distinct mechanisms: a mechanism for memory enhancement?
    Hutchinson DS; Summers RJ; Gibbs ME
    J Neurochem; 2007 Nov; 103(3):997-1008. PubMed ID: 17680985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of a novel series of biphenyl benzoic acid derivatives as highly potent and selective human beta3 adrenergic receptor agonists with good oral bioavailability. Part II.
    Imanishi M; Itou S; Washizuka K; Hamashima H; Nakajima Y; Araki T; Tomishima Y; Sakurai M; Matsui S; Imamura E; Ueshima K; Yamamoto T; Yamamoto N; Ishikawa H; Nakano K; Unami N; Hamada K; Matsumura Y; Takamura F; Hattori K
    J Med Chem; 2008 Jul; 51(13):4002-20. PubMed ID: 18553954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of Vibegron: A Potent and Selective β3 Adrenergic Receptor Agonist for the Treatment of Overactive Bladder.
    Edmondson SD; Zhu C; Kar NF; Di Salvo J; Nagabukuro H; Sacre-Salem B; Dingley K; Berger R; Goble SD; Morriello G; Harper B; Moyes CR; Shen DM; Wang L; Ball R; Fitzmaurice A; Frenkl T; Gichuru LN; Ha S; Hurley AL; Jochnowitz N; Levorse D; Mistry S; Miller RR; Ormes J; Salituro GM; Sanfiz A; Stevenson AS; Villa K; Zamlynny B; Green S; Struthers M; Weber AE
    J Med Chem; 2016 Jan; 59(2):609-23. PubMed ID: 26709102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tetrahydroisoquinoline derivatives containing a benzenesulfonamide moiety as potent, selective human beta3 adrenergic receptor agonists.
    Parmee ER; Brockunier LL; He J; Singh SB; Candelore MR; Cascieri MA; Deng L; Liu Y; Tota L; Wyvratt MJ; Fisher MH; Weber AE
    Bioorg Med Chem Lett; 2000 Oct; 10(20):2283-6. PubMed ID: 11055339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.